Nonalcoholic fatty liver disease: Targeted therapy in children - What is the right way?

Research output: Contribution to journalArticle

Abstract

The incidence of nonalcoholic fatty liver disease (NAFLD) in children is growing in parallel with that of obesity; however, to date, no drugs have been approved for its treatment. Results from a 5 year clinical trial show that neither metformin nor vitamin E are effective for the treatment of pediatric NAFLD.

Original languageEnglish
Pages (from-to)425-426
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Volume8
Issue number8
DOIs
Publication statusPublished - Aug 2011

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Fingerprint Dive into the research topics of 'Nonalcoholic fatty liver disease: Targeted therapy in children - What is the right way?'. Together they form a unique fingerprint.

  • Cite this